In depth evaluation of the prognostic and predictive utility of PTEN immunohistochemistry in colorectal carcinomas: performance of three antibodies with emphasis on intracellular and intratumoral heterogeneity-Reference-Cited by-同舟云学术

In depth evaluation of the prognostic and predictive utility of PTEN immunohistochemistry in colorectal carcinomas: performance of three antibodies with emphasis on intracellular and intratumoral heterogeneity

Published:2016-07-08 Issue:1 Volume:11 Page:
ISSN:1746-1596
Container-title:Diagnostic Pathology
language:en
Short-container-title:Diagn Pathol

Author:

Ágoston Emese Irma,Micsik Tamás,Ács Balázs,Fekete Krisztina,Hahn Oszkár,Baranyai Zsolt,Dede Kristóf,Bodoky György,Bursics Attila,Kulka Janina,Krenács Tibor,Győrffy Balázs,Harsányi László,Szász A. Marcell

Publisher

Springer Science and Business Media LLC

Subject

General Medicine,Histology,Pathology and Forensic Medicine

Link

http://link.springer.com/content/pdf/10.1186/s13000-016-0508-0

Reference41 articles.

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90.

2. De Roock W, De Vriendt V, Normanno N, Ciardiello F, Tejpar S. KRAS, BRAF, PIK3CA, and PTEN mutations: implications for targeted therapies in metastatic colorectal cancer. Lancet Oncol. 2011;12:594–603.

3. Di Bartolomeo M, Pietrantonio F, Perrone F, Dotti KF, Lampis A, Bertan C, Beretta E, Rimassa L, Carbone C, Biondani P, et al. Lack of KRAS, NRAS, BRAF and TP53 mutations improves outcome of elderly metastatic colorectal cancer patients treated with cetuximab, oxaliplatin and UFT. Targeted Oncol. 2013;1–8.

4. Li P, Wang D, Li H, Yu Z, Chen X, Fang J. Identification of nucleolus-localized PTEN and its function in regulating ribosome biogenesis. Mol Biol Rep. 2014.

5. Sansal I, Sellers WR. The biology and clinical relevance of the PTEN tumor suppressor pathway. J Clin Oncol. 2004;22:2954–63.

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Semiquantitative assessment of phosphatase and tensin homolog value with immunohistochemistry in colorectal cancer;The International Journal of Biological Markers;2024-08-09

2. The Clinicopathological Correlation of KRAS Mutation and PTEN Expression Status in Primary and Metastatic Colorectal Carcinoma;Cureus;2024-02-08

3. Colorectal Cancer: From Genetic Landscape to Targeted Therapy;Journal of Oncology;2021-07-06

4. PTEN Is Involved in Sunitinib and Sorafenib Resistance in Renal Cell Carcinoma;Anticancer Research;2020-03-31

5. PTEN in Colorectal Cancer: Shedding Light on Its Role as Predictor and Target;Cancers;2019-11-09